• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Ying-huan, ZONG Li, ZHU Jia-bi. Formulation optimization of PEGylated cationic liposomes as siRNA delivery system[J]. Journal of China Pharmaceutical University, 2011, 42(5): 412-417.
Citation: LI Ying-huan, ZONG Li, ZHU Jia-bi. Formulation optimization of PEGylated cationic liposomes as siRNA delivery system[J]. Journal of China Pharmaceutical University, 2011, 42(5): 412-417.

Formulation optimization of PEGylated cationic liposomes as siRNA delivery system

More Information
  • PEGylated cationic liposomes containing 0%-5% (mole fraction) 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (PEG) were studied as siRNA delivery system.Two groups of cationic liposomes containing 1,2-dioleoyl-3-trimethylammoniumpropane (DOTAP) with mole fraction of 20% and 40% respectively were prepared.The kinetic changes on tumor cellular membrane binding and internalization vs different time and different extracellular liposomal concentration were compared.Binding reached the equilibrium at 4 h for all tested liposomes.Cationic liposomes containing 40% (mole fraction) of DOTAP showed higher cell-association amount than those containing 20% (mole fraction) of DOTAP.Cell-membrane binding time course was changed from nonsaturable to saturable kinetics after PEGylation.Cationic liposomes containing 40% (mole fraction) of DOTAP and 0%-2% (mole fraction) of PEG were shown to successfully transfer siRNA to cytosol under confocal microscope, while those with 5% (mole fraction) PEG failed.
  • Related Articles

    [1]ZHANG Yuwen, YU Chenlin, DAI Xinchen, XIAO Yibei, LU Meiling. Structural feature of type I CRISPR-Cas system and its application in gene editing[J]. Journal of China Pharmaceutical University, 2021, 52(6): 675-683. DOI: 10.11665/j.issn.1000-5048.20210604
    [2]YU Zexuan, JU Caoyun, ZHANG Can. Construction and application of gene delivery systems for primary dendritic cells[J]. Journal of China Pharmaceutical University, 2021, 52(4): 438-446. DOI: 10.11665/j.issn.1000-5048.20210406
    [3]PAN Xiuhua, WU Zhenghong, QI Xiaole. Research status and application progress of CRISPR/Cas9 delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(1): 10-18. DOI: 10.11665/j.issn.1000-5048.20200102
    [4]WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303
    [5]WANG Shu, ZHANG Zhenhai, GU Dongfei, ZHOU Jianping, LYV Huixia. Advances of exosomes as a new drug delivery system[J]. Journal of China Pharmaceutical University, 2014, 45(2): 247-252. DOI: 10.11665/j.issn.1000-5048.20140221
    [6]WU Qu, HUO Meirong, ZHOU Jianping. Advances on novel drug delivery system[J]. Journal of China Pharmaceutical University, 2013, 44(2): 97-104. DOI: 10.11665/j.issn.1000-5048.20130201
    [7]TANG Yue, KE Xue. Advances of mesoporous silica nanoparticles as drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(6): 567-572.
    [8]KE Xue. Advances in targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(1): 9-15.
    [9]Studies on Optimizing the Formula of Nitrendipine Selfemulsifying Drug Delivery System[J]. Journal of China Pharmaceutical University, 2004, (3): 17-20.
    [10]A Preliminary Transdermal Delivery System of Levonorgestrel[J]. Journal of China Pharmaceutical University, 1992, (6): 344-347.

Catalog

    Article views (1536) PDF downloads (2311) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return